Results 241 to 250 of about 142,807 (311)

Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study

open access: yesMovement Disorders, EarlyView.
Abstract Background Serum neurofilament light chain (NfL) levels, a marker of axonal damage, are generally elevated in neurodegenerative conditions, but results in idiopathic Parkinson's disease (iPD) have been inconsistent. The p.A53T SNCA mutation usually leads to a severe form of PD.
Nikolaos Papagiannakis   +213 more
wiley   +1 more source

Intratumoral Bacteria: Accomplices in Cancer Progression and Emerging Therapeutic Targets

open access: yesMedicine Advances, EarlyView.
Intratumoral bacteria are no longer seen as contaminants but as active contributors to cancer progression, driving therapy resistance and metastasis through metabolic reprogramming, immunomodulation, and metastatic niche formation. This review highlights emerging microbiome‐targeted strategies—including synthetic microbial consortia, engineered ...
Jie Yang   +3 more
wiley   +1 more source

A PLP‐SEC Investigation of Di(Ethylene Glycol) Methyl Ether Methacrylate Radical Polymerization Propagation Kinetics in Solution

open access: yesMacromolecular Reaction Engineering, EarlyView.
The propagation rate coefficient of di(ethylene glycol) methyl ether methacrylate exhibits the same temperature dependency but is a factor of 12 higher in aqueous solution compared to bulk. Smaller increases are observed in ethanol and ethanol/water mixtures, with the value of the rate coefficient decreasing as the monomer concentration in solution is ...
Fatemeh Salarhosseini   +1 more
wiley   +1 more source

Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders

open access: yesNeuroprotection, EarlyView.
The graphical abstract encapsulates the dual neuroprotective mechanisms of statins in neurodegenerative diseases, highlighting both cholesterol‐dependent and cholesterol‐independent pathways. By inhibiting 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase, statins reduce cholesterol synthesis, leading to altered lipid raft structures that ...
Jun Han Kuan   +5 more
wiley   +1 more source

Aurora: Mechanism and Excitation Process

open access: diamond
Mukul Tewari   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy